Health
New Data Boosts Confidence In J&J Vaccine – Barron’s
Results of a large Phase 3 trial are expected in the coming weeks. It is expected to show the single-dose vaccine is very effective, if not quite as effective as…
New data on early-stage trials of
Johnson & Johnsons
Covid-19 vaccine are giving experts increased confidence that the vaccine will work as they await results of a large Phase 3 trial expected in the coming weeks.The trial data, published Wednesday by the New England Journal of Medicine, offered an expanded and updated account of a paper posted weeks ago on a so-called preprint server. The paper showed that 90% or more of participants developed neutralizing antibodies against the virus that causes…
-
General14 hours agoCoroner to examine treatment of woman who died three days after surgery performed by former Queensland premier’s partner
-
Business14 hours agoWhy Antipa, Cettire, Magnetic Resources, and Steadfast shares are pushing higher
-
General16 hours agoToo skewed, too gentlemanly | The Spectator Australia
-
General17 hours agoAlbanese beats drum on economy as trade clouds gather